MSKCC
Memorial Sloan Kettering Cancer Center Portfolio holdings
AUM $24.6M
1-Year Return
10.16%
This Quarter Return
-0.77%
1 Year Return
+10.16%
3 Year Return
-15.77%
5 Year Return
–
10 Year Return
–
AUM
$86.4M
AUM Growth
-$72.8M
(-46%)
Cap. Flow
-$64.1M
Cap. Flow
% of AUM
-74.2%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Royalty Pharma
RPRX
|
+$60.5M |
| 2 |
Illumina
ILMN
|
+$3.6M |
Sector Composition
| 1 | Healthcare | 67.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Royalty Pharma
RPRX
$15.2B
| $44M | 50.9% |
1,128,255
-1,552,389
| -58% | -$60.5M |
|
2
VanEck Gold Miners ETF
GDX
$20.5B
| $28.3M | 32.79% |
738,500
| – | – |
|
3
Caribou Biosciences
CRBU
$170M
| $6.19M | 7.17% |
674,196
| – | – |
|
4
Oric Pharmaceuticals
ORIC
$1.04B
| $3.22M | 3.72% |
602,272
| – | – |
|
|
5
Illumina
ILMN
$15.5B
| $2.41M | 2.79% |
7,080
-10,597
| -60% | -$3.6M |
|
6
Y-mAbs Therapeutics
YMAB
$391M
| $2.27M | 2.63% |
191,176
| – | – |
|